RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Series A | USD 2,500,000 | ||
|
Sword Health | Series A | USD 8,000,000 | |||
|
|
Sword Health | Seed | USD 4,600,000 | |||
|
Zilico Ltd | Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology. | Venture | USD 19,000,000 | ||
|
Cardiac Insight Inc | Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states. | Series C-1 | USD 4,500,000 | ||
|
Sinovision Technology (Beijing) Co Ltd | Developer of computed tomography (CT) scanners. | Venture | CNY 200,000,000 | ||
|
Auris Surgical Robotics Inc | Venture | USD 280,000,000 | |||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | PLN 6,500,000 | ||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | USD 2,000,000 | ||
|
Intrinsic Therapeutics Inc | Debt | USD 21,000,000 |
MOST ACTIVE INVESTORS
MOST ACTIVE ACQUIRERS
| Auris Surgical Robotics Inc | US | 1 |
BEST FUNDED
Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology.
Medically certified AI algorithms and device for automatic and remote lung and heart screening.
Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states.
Canadian medical device company and the world leader in fluorescence endoscopy for improved cancer detection.
Growth stage venture capital fund focused on investments in late stage high-tech companies.
High performance nucleic acid purification, enrichment, and sequence detection.
Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes.
Developer of a new patented diagnostic test system that will significantly improve identification and treatment of glaucoma
Developer of home haemodialysis systems, called “SelfCare”.